Literature DB >> 21862879

GABARAPL1 antibodies: target one protein, get one free!

Jaclyn Nicole Le Grand1, Fatima Zahra Chakrama, Stéphanie Seguin-Py, Annick Fraichard, Régis Delage-Mourroux, Michèle Jouvenot, Pierre-Yves Risold, Michaël Boyer-Guittaut.   

Abstract

Atg8 is a yeast protein involved in the autophagic process and in particular in the elongation of autophagosomes. In mammals, several orthologs have been identified and are classed into two subfamilies: the LC3 subfamily and the GABARAP subfamily, referred to simply as the LC3 or GABARAP families. GABARAPL1 (GABARAP-like protein 1), one of the proteins belonging to the GABARAP (GABA(A) receptor-associated protein) family, is highly expressed in the central nervous system and implicated in processes such as receptor and vesicle transport as well as autophagy. The proteins that make up the GABARAP family demonstrate conservation of their amino acid sequences and protein structures. In humans, GABARAPL1 shares 86% identity with GABARAP and 61% with GABARAPL2 (GATE-16). The identification of the individual proteins is thus very limited when working in vivo due to a lack of unique peptide sequences from which specific antibodies can be developed. Actually, and to our knowledge, there are no available antibodies on the market that are entirely specific to GABARAPL1 and the same may be true of the anti-GABARAP antibodies. In this study, we sought to examine the specificity of three antibodies targeted against different peptide sequences within GABARAPL1: CHEM-CENT (an antibody raised against a short peptide sequence within the center of the protein), PTG-NTER (an antibody raised against the N-terminus of the protein) and PTG-FL (an antibody raised against the full-length protein). The results described in this article demonstrate the importance of testing antibody specificity under the conditions for which it will be used experimentally, a caution that should be taken when studying the expression of the GABARAP family proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862879     DOI: 10.4161/auto.7.11.16723

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  6 in total

1.  Essential role for GABARAP autophagy proteins in interferon-inducible GTPase-mediated host defense.

Authors:  Miwa Sasai; Naoya Sakaguchi; Ji Su Ma; Shuhei Nakamura; Tsuyoshi Kawabata; Hironori Bando; Youngae Lee; Tatsuya Saitoh; Shizuo Akira; Akiko Iwasaki; Daron M Standley; Tamotsu Yoshimori; Masahiro Yamamoto
Journal:  Nat Immunol       Date:  2017-06-12       Impact factor: 25.606

2.  ATG8 family proteins act as scaffolds for assembly of the ULK complex: sequence requirements for LC3-interacting region (LIR) motifs.

Authors:  Endalkachew Ashenafi Alemu; Trond Lamark; Knut Martin Torgersen; Aasa Birna Birgisdottir; Kenneth Bowitz Larsen; Ashish Jain; Hallvard Olsvik; Aud Øvervatn; Vladimir Kirkin; Terje Johansen
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

3.  Specific distribution of the autophagic protein GABARAPL1/GEC1 in the developing and adult mouse brain and identification of neuronal populations expressing GABARAPL1/GEC1.

Authors:  Jaclyn Nicole Le Grand; Karine Bon; Annick Fraichard; Jianhua Zhang; Michèle Jouvenot; Pierre-Yves Risold; Michaël Boyer-Guittaut; Régis Delage-Mourroux
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

4.  Western Blotting Inaccuracies with Unverified Antibodies: Need for a Western Blotting Minimal Reporting Standard (WBMRS).

Authors:  Jennifer E Gilda; Rajeshwary Ghosh; Jenice X Cheah; Toni M West; Sue C Bodine; Aldrin V Gomes
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

5.  Redundancy of human ATG4 protease isoforms in autophagy and LC3/GABARAP processing revealed in cells.

Authors:  Alexander Agrotis; Niccolo Pengo; Jemima J Burden; Robin Ketteler
Journal:  Autophagy       Date:  2019-02-01       Impact factor: 16.016

6.  Protein-protein interaction networks identify targets which rescue the MPP+ cellular model of Parkinson's disease.

Authors:  Harriet Keane; Brent J Ryan; Brendan Jackson; Alan Whitmore; Richard Wade-Martins
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.